High rate of hypothyroidism among patients treated for multidrug-resistant tuberculosis in Lesotho

Abstract

Hypothyroidism may be more common during MDR-TB treatment than previously recognized. Screening all patients, even those without symptoms, for hypothyroidism within 2-3 months of starting MDR-TB treatment should be considered until prospective studies can inform screening guidelines.